bioRxivNeurosciencePreprint
Identification of Common genes and proteins in Alzheimer's Disease, Multiple Sclerosis and Duchenne Muscular Dystrophy using in-silico methods.
Subhankar Kumar SinghiD, Souvik ChakrabortyiD, Tarasankar MaitiiD, Anuska Chakraborty
Abstract
Alzheimers is a type of dementia symptom that slowly worsens over some time. In its early stages, memory loss is mild, but with late-stage Alzheimers, the patient loses the ability to carry on a conversation and respond to their environment. Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized by chronic inflammation, demyelination, gliosis, and neuronal loss. Duchenne muscular dystrophy (DMD) is one of the most severe forms of inherited muscular dystrophies. It is the most common hereditary neuromuscular disease and does not exhibit a predilection for any race or ethnic group. In this study, several gene expression study data were analyzed and there were 557 Differentially Expressed Genes (DEGs) in all three chosen Datasets. A protein-protein interaction network was created using STRING and CytoHubba plug-in was used to identify the top ten genes which are POLR2A, SETD2, EFTUD2, RBM25, PRPF40A, CDK13, BPTF, THOC2, SNRNP70, and SCAF11. Online software Enrichr was used for Gene Ontology and KEGG pathway enrichment analysis to find out the biological process, molecular function, cellular component, and the pathways that are commonly affected in these diseases.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of conserved proteomic networks in neurodegenerative dementia
Vivek Swarup, Timothy S. Chang, … Daniel H. Geschwind·Cell ReportsPeer-reviewed·Jun 1, 2020
- Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in Alzheimer disease
Basavaraj Mallikarjunayya Vastrad, Chanabasayya Mallikarjunayya Vastrad·bioRxiv·May 6, 2021
- Identification of potential proteins and microRNAs in Multiple Sclerosis and Huntington's diseases using in silico methods.
Tarasankar Maiti, Souvik Chakraborty·bioRxiv·Sep 19, 2021
- Identifying potential key genes and existing drugs for Multiple sclerosis, Schizophrenia, and Autism- an in silico approach
Sajal Kumar Dey, Sushmita Bhowmick, Souvik Chakraborty·bioRxiv·Nov 30, 2021
- Common Dysregulated Pathways and Genes in Alzheimer's, Parkinson's, and Huntington's Diseases: A Computational Analysis to Nominate Candidate Gene Targets for Drug Repurposing
Nehal Adel Abdelsalam, Muhammad Elsadany, Eman Badr·bioRxiv·Jul 25, 2026
- Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease
Jin Xu, Giulia Bankov, … Cristina Legido‐Quigley·Translational NeurodegenerationPeer-reviewed·Sep 20, 2020